Quantity size:

0.2ml

Concentration:

1mg/ml 诱捕受体2抗体  Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

Apoptosis is induced by certain cytokines including TNF and Fas ligand in the TNF family through their death domain containing receptors. TRAIL/Apo2L, a member of the TNF family, induces apoptosis of a variety of tumor cell lines. DR4 and DR5 are functional receptors for TRAIL, and DcR1/TRID is a decoy receptor. Another member of the TRAIL receptor family was identified and designated DcR2. The DcR2 receptor is 386 amino acids in length and has an extracellular TRAIL binding domain, but lacks intracellular death domain and does not induce apoptosis. Although this receptor诱捕受体2抗体  binds to the cytotoxic ligand TRAIL, it contains a truncated death domain and functions as an inhibitory receptor. When overexpressed, the DcR2 receptor can protect cells against TRAIL mediated cytotoxicity. Like DR4 and DR5, DcR2 transcript is widely expressed in a variety of normal human tissues but DcR2 is absent in most tumors. Ultraviolet radiation has been shown to upregulate DcR2 expression on human keratinocytes. Over expression of DcR2 attenuated TRAIL induced apoptosis.

诱捕受体2抗体 Also known as:

TNFRSF10D; Decoy receptor 2; CD 264; CD264; DcR 2; decoy with truncated death domain; ID; TNF receptor related receptor for TRAIL; TNF related apoptosis inducing ligand receptor 4; TNFRSF 10D; TRAIL R4; TRAIL receptor 4; TRAIL receptor with a truncated death domain; TRAILR4; TRIALR 4; TRUNDD; Tumor necrosis factor receptor superfamily member 10d decoy with truncated death domain; Tumor necrosis factor receptor superfamily member 诱捕受体2抗体 10D precursor; TR10D_HUMAN.

Specificity:

●

Rabbit Polyclonal IgG, affinity purified by Protein A.

●

Reacts with: Human, .

●

Immunogen: KLH conjugated synthetic peptide derived from human DcR2/CD2.

●

诱捕受体2抗体 Predicted Molecular Weight: 36kDa.

Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

WB=1:100-500  ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  ICC=1:100-500  IF=1:100-500   
Not yet tested in other applications. 
Optimal working dilutions must be determined by the end user.

kl966Mu01多配体蛋白聚糖1(SDC1)多克隆抗体Polyclonal Antibody to Syndecan 1 (SDC1)

kl966Ra01多配体蛋白聚糖1(SDC1)多克隆抗体Polyclonal Antibody to Syndecan 1 (SDC1)

kl967Hu01载脂蛋白A4(APOA4)多克隆抗体Polyclonal Antibody to Apolipoprotein A4 (APOA4)

kl967Mu01载脂蛋白A4(APOA4)多克隆抗体Polyclonal Antibody to Apolipoprotein A4 (APOA4)

kl967Po01载脂蛋白A4(APOA4)多克隆抗体Polyclonal Antibody to Apolipoprotein A4 (APOA4)

kl968Hu01载脂蛋白D(APOD)多克隆抗体Polyclonal Antibody to Apolipoprotein D (APOD)

kl969Mu01补体成分5(C5)多克隆抗体Polyclonal Antibody to Complement Component 5 (C5)

kl969Ra01补体成分5(C5)多克隆抗体Polyclonal Antibody to Complement Component 5 (C5)

kl970Hu01补体成分8γ(C8γ)多克隆抗体Polyclonal Antibody to Complement Component 8g (C8g)

kl971Hu01蛋白S(PROS)多克隆抗体Polyclonal Antibody to Protein S (PROS)

kl972Hu01色素上皮衍生因子(PEDF)多克隆抗体Polyclonal Antibody to Pigment Epithelium Derived Factor (PEDF)

kl972Mu01色素上皮衍生因子(PEDF)多克隆抗体Polyclonal Antibody to Pigment Epithelium Derived Factor (PEDF)

kl973Hu01血小板反应蛋白解整合素金属肽酶1(ADAMTS1)多克隆抗体Polyclonal Antibody to A Disintegrin And Metalloproteinase With Thrombospondin 1 (ADAMTS1)

kl973Ra01血小板反应蛋白解整合素金属肽酶1(ADAMTS1)多克隆抗体Polyclonal Antibody to A Disintegrin And Metalloproteinase With Thrombospondin 1 (ADAMTS1)

kl974Hu01血小板反应蛋白解整合素金属肽酶7(ADAMTS7)多克隆抗体Polyclonal Antibody to A Disintegrin And Metalloproteinase With Thrombospondin 7 (ADAMTS7)

kl974Ra01血小板反应蛋白解整合素金属肽酶7(ADAMTS7)多克隆抗体Polyclonal Antibody to A Disintegrin And Metalloproteinase With Thrombospondin 7 (ADAMTS7)

kl975Hu01肌腱蛋白C(TNC)多克隆抗体Polyclonal Antibody to Tenascin C (TNC)

kl975Ra01肌腱蛋白C(TNC)多克隆抗体Polyclonal Antibody to Tenascin C (TNC)

kl978Hu01补体因子I(CFI)多克隆抗体Polyclonal Antibody to Complement Factor I (CFI)

kl979Hu01铁调素(Hepc)多克隆抗体Polyclonal Antibody to Hepcidin (Hepc)